MedPath
NMPA Approval

Plerixafor Injection

国药准字J20190003

February 7, 2020

H20180075H20194001

Drug Information

普乐沙福注射液

释倍灵

释倍灵

注射剂

1.2ml:24mg

化学药品

February 7, 2020

Company Information

Applicant Company

Paasheuvelweg 25,1105 BP Amsterdam,The Netherlands

Manufacturing Company

1125 Pleasant View Terrace,Ridgefield,NJ 07657,United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

普乐沙福注射液 - NMPA 批准文号 | MedPath